Amyloid Brain Positron Emission Tomography (PET) Imaging With 11C-PIB and Tau PET Imaging With 18F-MK-6240 in the Diabetes Prevention Program Outcomes Study
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Florquinitau F18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Acronyms DPPOS-Brain
- 01 Mar 2024 Status changed from recruiting to discontinued (due to difficulty recruiting (the COVID-19 pandemic) and end of funding).
- 08 Jul 2021 Planned End Date changed from 31 Jan 2021 to 31 Jan 2022.
- 08 Jul 2021 Planned primary completion date changed from 31 Jan 2021 to 31 Jan 2022.